Safeguard Scientifics (Safeguard Scientifics) ROCE % : -30.96% (As of Dec. 2023)

View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Safeguard Scientifics's annualized ROCE % for the quarter that ended in Dec. 2023 was -30.96%.

Safeguard Scientifics ROCE % Historical Data

The historical data trend for Safeguard Scientifics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safeguard Scientifics ROCE % Chart

Safeguard Scientifics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

62.94

-11.09

-12.14

-10.83

-20.06

Safeguard Scientifics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-10.70	-13.85	-15.20	-17.31	-30.96

Safeguard Scientifics ROCE % Calculation

Safeguard Scientifics's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-5.683	/	( ( (37.692 - 1.817)	+	(22.836 - 2.046) )	/ 2 )
	=	-5.683	/	( (35.875	+	20.79)	/ 2 )
	=	-5.683	/	28.3325
	=	-20.06 %

Safeguard Scientifics's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-7.996	/	( ( (32.427 - 1.563)	+	(22.836 - 2.046) )	/ 2 )
	=	-7.996	/	( ( 30.864	+	20.79 )	/ 2 )
	=	-7.996	/	25.827
	=	-30.96 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Safeguard Scientifics (OTCPK:SFES) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Safeguard Scientifics ROCE % Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Safeguard Scientifics (Safeguard Scientifics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SFU:Germany

Address

150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087

Website

https://www.safeguard.com

Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. Safeguard generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders.

Executives

Satterfield Thomas A Jr	10 percent owner	2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson	director	C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont	director	51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr.	director	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal	director	20 NEWBURY ST, BOSTON MA 02116
Mark Herndon	officer: SVP & Chief Financial Officer	C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman	officer: Chief Restructuring Officer	C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert	director	C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts	director	1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko	officer: Senior V.P. & General Counsel	435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass	director	170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille	officer: Senior VP & CFO	C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison	director	C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli	officer: Acting Sr VP & Acting CFO	FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz	director	P O BOX 738, RYE NH 03870